Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Bhang HE"'
Autor:
Hata AN; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Niederst MJ; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Archibald HL; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts, USA., Gomez-Caraballo M; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts, USA., Siddiqui FM; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts, USA., Mulvey HE; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts, USA., Maruvka YE; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts, USA.; Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University, Cambridge, Massachusetts, USA., Ji F; Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts, USA., Bhang HE; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Krishnamurthy Radhakrishna V; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Siravegna G; Department of Oncology, University of Torino, Torino, Italy.; Candiolo Cancer Institute-Fondazione Piemontese per l'Oncologia (FPO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Candiolo, Italy., Hu H; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts, USA., Raoof S; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Lockerman E; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts, USA., Kalsy A; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts, USA., Lee D; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts, USA., Keating CL; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Ruddy DA; Translational Clinical Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Damon LJ; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts, USA., Crystal AS; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts, USA., Costa C; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Piotrowska Z; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Bardelli A; Department of Oncology, University of Torino, Torino, Italy.; Candiolo Cancer Institute-Fondazione Piemontese per l'Oncologia (FPO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Candiolo, Italy., Iafrate AJ; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA., Sadreyev RI; Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA., Stegmeier F; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Getz G; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts, USA.; Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University, Cambridge, Massachusetts, USA.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA., Sequist LV; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Faber AC; Virginia Commonwealth University Philips Institute for Oral Health Research, Virginia Commonwealth University School of Dentistry, Richmond, Virginia, USA.; Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia, USA., Engelman JA; Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Nature medicine [Nat Med] 2016 Mar; Vol. 22 (3), pp. 262-9. Date of Electronic Publication: 2016 Feb 01.
Autor:
Röck R; Institute of Biochemistry and Center for Molecular Biosciences, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria., Bachmann V; Institute of Biochemistry and Center for Molecular Biosciences, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria., Bhang HE; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical School, Baltimore, MD 21287, USA., Malleshaiah M; Département de Biochimie, Université de Montréal, H3C 3J7 Montréal, Québec, Canada., Raffeiner P; Institute of Biochemistry and Center for Molecular Biosciences, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria., Mayrhofer JE; Institute of Biochemistry and Center for Molecular Biosciences, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria., Tschaikner PM; Institute of Molecular Biology, University of Innsbruck, Technikerstrasse 25, 6020 Innsbruck, Austria., Bister K; Institute of Biochemistry and Center for Molecular Biosciences, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria., Aanstad P; Institute of Molecular Biology, University of Innsbruck, Technikerstrasse 25, 6020 Innsbruck, Austria., Pomper MG; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical School, Baltimore, MD 21287, USA., Michnick SW; Département de Biochimie, Université de Montréal, H3C 3J7 Montréal, Québec, Canada., Stefan E; Institute of Biochemistry and Center for Molecular Biosciences, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria.
Publikováno v:
Scientific reports [Sci Rep] 2015 Jun 23; Vol. 5, pp. 11133. Date of Electronic Publication: 2015 Jun 23.
Autor:
Bhang HE; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Ruddy DA; Translational Clinical Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Krishnamurthy Radhakrishna V; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Caushi JX; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Zhao R; 1] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA., Hims MM; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Singh AP; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Kao I; Translational Clinical Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Rakiec D; Translational Clinical Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Shaw P; Translational Clinical Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Balak M; Translational Clinical Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Raza A; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Ackley E; Translational Clinical Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Keen N; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Schlabach MR; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Palmer M; Translational Clinical Oncology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Leary RJ; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Chiang DY; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Sellers WR; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Michor F; 1] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA., Cooke VG; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Korn JM; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Stegmeier F; Oncology Disease Area, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.
Publikováno v:
Nature medicine [Nat Med] 2015 May; Vol. 21 (5), pp. 440-8. Date of Electronic Publication: 2015 Apr 13.
Autor:
Rahal R; 1] Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA. [2]., Frick M; 1] Department of Hematology, Oncology and Tumor Immunology, Molecular Cancer Research Center, Charité-Universitätsmedizin, Berlin, Germany. [2]., Romero R; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Korn JM; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Kridel R; Department of Pathology and Experimental Therapeutics, BC Cancer Agency and BC Cancer Research Centre, Vancouver, British Columbia, Canada., Chan FC; Department of Pathology and Experimental Therapeutics, BC Cancer Agency and BC Cancer Research Centre, Vancouver, British Columbia, Canada., Meissner B; Department of Pathology and Experimental Therapeutics, BC Cancer Agency and BC Cancer Research Centre, Vancouver, British Columbia, Canada., Bhang HE; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Ruddy D; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Kauffmann A; Novartis Institutes for Biomedical Research, Basel, Switzerland., Farsidjani A; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Derti A; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Rakiec D; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Naylor T; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Pfister E; Novartis Institutes for Biomedical Research, Basel, Switzerland., Kovats S; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Kim S; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Dietze K; Department of Hematology, Oncology and Tumor Immunology, Molecular Cancer Research Center, Charité-Universitätsmedizin, Berlin, Germany., Dörken B; Department of Hematology, Oncology and Tumor Immunology, Molecular Cancer Research Center, Charité-Universitätsmedizin, Berlin, Germany., Steidl C; Department of Pathology and Experimental Therapeutics, BC Cancer Agency and BC Cancer Research Centre, Vancouver, British Columbia, Canada., Tzankov A; Institute of Pathology, University Hospital Basel, Basel, Switzerland., Hummel M; Department of Pathology, Charité-Universitätsmedizin, Berlin, Germany., Monahan J; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Morrissey MP; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Fritsch C; Novartis Institutes for Biomedical Research, Basel, Switzerland., Sellers WR; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Cooke VG; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA., Gascoyne RD; Department of Pathology and Experimental Therapeutics, BC Cancer Agency and BC Cancer Research Centre, Vancouver, British Columbia, Canada., Lenz G; 1] Department of Hematology, Oncology and Tumor Immunology, Molecular Cancer Research Center, Charité-Universitätsmedizin, Berlin, Germany. [2]., Stegmeier F; 1] Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA. [2].
Publikováno v:
Nature medicine [Nat Med] 2014 Jan; Vol. 20 (1), pp. 87-92. Date of Electronic Publication: 2013 Dec 22.
Autor:
Jaffe JD; 1] The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA. [2]., Wang Y, Chan HM, Zhang J, Huether R, Kryukov GV, Bhang HE, Taylor JE, Hu M, Englund NP, Yan F, Wang Z, Robert McDonald E 3rd, Wei L, Ma J, Easton J, Yu Z, deBeaumount R, Gibaja V, Venkatesan K, Schlegel R, Sellers WR, Keen N, Liu J, Caponigro G, Barretina J, Cooke VG, Mullighan C, Carr SA, Downing JR, Garraway LA, Stegmeier F
Publikováno v:
Nature genetics [Nat Genet] 2013 Nov; Vol. 45 (11), pp. 1386-91. Date of Electronic Publication: 2013 Sep 29.
Autor:
Bhang HE; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA., Pomper MG
Publikováno v:
The international journal of biochemistry & cell biology [Int J Biochem Cell Biol] 2012 May; Vol. 44 (5), pp. 684-9. Date of Electronic Publication: 2012 Feb 10.
Autor:
Park J; Department of Materials Science and Engineering and Institute for Nanobiotechnology, Johns Hopkins University, 3400 N. Charles St., Baltimore, MD 21218, USA., Dvoracek C, Lee KH, Galloway JF, Bhang HE, Pomper MG, Searson PC
Publikováno v:
Small (Weinheim an der Bergstrasse, Germany) [Small] 2011 Nov 18; Vol. 7 (22), pp. 3148-52. Date of Electronic Publication: 2011 Sep 21.
Autor:
Bhang HE; Department of Pharmacology and Molecular Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA., Gabrielson KL, Laterra J, Fisher PB, Pomper MG
Publikováno v:
Nature medicine [Nat Med] 2011 Jan; Vol. 17 (1), pp. 123-9. Date of Electronic Publication: 2010 Dec 12.
Autor:
Shim JS; Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA., Matsui Y, Bhat S, Nacev BA, Xu J, Bhang HE, Dhara S, Han KC, Chong CR, Pomper MG, So A, Liu JO
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2010 Dec 15; Vol. 102 (24), pp. 1855-73. Date of Electronic Publication: 2010 Nov 18.
Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studies.
Autor:
Wang H; Department of Radiology, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA., Byun Y, Barinka C, Pullambhatla M, Bhang HE, Fox JJ, Lubkowski J, Mease RC, Pomper MG
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2010 Jan 01; Vol. 20 (1), pp. 392-7. Date of Electronic Publication: 2009 Oct 24.